MMSI MERIT MED SYS INC revenue, earnings and financials

For the quarter ended June 30, 2026, MERIT MED SYS INC reported revenue of $419M (up 9.5% from a year earlier), net income of $38.8M and diluted EPS of $0.65; over the last four quarters revenue was $1.58B and net income $146M; for the fiscal year ended December 2025 revenue was $1.52B, up 11.8% on the year before.

MMSI annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.52B, gross profit $738M, operating income $185M, net income $128M (margin 8.5%), EPS $2.13
• Fiscal year ended Dec 2024: revenue $1.36B, gross profit $643M, operating income $156M, net income $120M (margin 8.9%), EPS $2.03
• Fiscal year ended Dec 2023: revenue $1.26B, gross profit $584M, operating income $124M, net income $94.4M (margin 7.5%), EPS $1.62
• Fiscal year ended Dec 2022: revenue $1.15B, gross profit $519M, operating income $87.6M, net income $74.5M (margin 6.5%), EPS $1.29
• Fiscal year ended Dec 2021: revenue $1.07B, gross profit $485M, operating income $60.9M, net income $48.5M (margin 4.5%), EPS $0.84

MMSI quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $419M (up 9.5% year over year), net income $38.8M, EPS $0.65
• Quarter ended Mar 31, 2026: revenue $382M (up 7.5% year over year), net income $41.0M, EPS $0.68
• Quarter ended Dec 31, 2025 (from the annual report): revenue $394M (up 10.9% year over year), net income $38.0M, EPS $0.64
• Quarter ended Sep 30, 2025: revenue $384M (up 13.0% year over year), net income $27.8M, EPS $0.46
• Quarter ended Jun 30, 2025: revenue $382M (up 13.2% year over year), net income $32.6M, EPS $0.54
• Quarter ended Mar 31, 2025: revenue $355M (up 9.8% year over year), net income $30.1M, EPS $0.49
• Quarter ended Dec 31, 2024 (from the annual report): revenue $355M (up 9.4% year over year), net income $27.9M, EPS $0.46
• Quarter ended Sep 30, 2024: revenue $340M (up 7.8% year over year), net income $28.4M, EPS $0.48
• Quarter ended Jun 30, 2024: revenue $338M (up 5.6% year over year), net income $35.7M, EPS $0.61
• Quarter ended Mar 31, 2024: revenue $324M (up 8.7% year over year), net income $28.2M, EPS $0.48
• Quarter ended Dec 31, 2023 (from the annual report): revenue $325M (up 10.6% year over year), net income $27.6M, EPS $0.47
• Quarter ended Sep 30, 2023: revenue $315M (up 9.8% year over year), net income $25.8M, EPS $0.44
• Quarter ended Jun 30, 2023: revenue $320M (up 8.5% year over year), net income $20.2M, EPS $0.35
• Quarter ended Mar 31, 2023: revenue $298M (up 8.0% year over year), net income $20.7M, EPS $0.36
• Quarter ended Dec 31, 2022 (from the annual report): revenue $293M (up 5.4% year over year), net income $33.4M, EPS $0.57
• Quarter ended Sep 30, 2022: revenue $287M (up 7.5% year over year), net income $15.3M, EPS $0.27
• Quarter ended Jun 30, 2022: revenue $295M (up 5.2% year over year), net income $15.3M, EPS $0.27
• Quarter ended Mar 31, 2022: revenue $275M (up 10.6% year over year), net income $10.5M, EPS $0.18
• Quarter ended Dec 31, 2021 (from the annual report): revenue $278M, net income $20.6M, EPS $0.35
• Quarter ended Sep 30, 2021: revenue $267M, net income $12.0M, EPS $0.21

MMSI cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $297M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $221M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $145M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $114M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $147M, share buybacks n/a

MMSI balance sheet

• Jun 30, 2026: cash $449M, total assets $2.86B, total liabilities $1.18B, shareholders' equity $1.68B, long-term debt $736M
• Mar 31, 2026: cash $488M, total assets $2.72B, total liabilities $1.09B, shareholders' equity $1.63B, long-term debt $735M
• Dec 31, 2025: cash $446M, total assets $2.69B, total liabilities $1.10B, shareholders' equity $1.58B, long-term debt $734M
• Sep 30, 2025: cash $392M, total assets $2.63B, total liabilities $1.10B, shareholders' equity $1.53B, long-term debt $733M
• Jun 30, 2025: cash $342M, total assets $2.59B, total liabilities $1.10B, shareholders' equity $1.49B, long-term debt $732M
• Mar 31, 2025: cash $396M, total assets $2.47B, total liabilities $1.04B, shareholders' equity $1.43B, long-term debt $731M
• Dec 31, 2024: cash $377M, total assets $2.42B, total liabilities $1.04B, shareholders' equity $1.38B, long-term debt $730M
• Sep 30, 2024: cash $523M, total assets $2.38B, total liabilities $1.05B, shareholders' equity $1.32B, long-term debt $751M

What is MMSI's revenue?

MERIT MED SYS INC reported $1.58B of revenue over its last four quarters, through June 30, 2026.

Is MMSI profitable?

Yes. MERIT MED SYS INC earned $146M over the last four quarters.

What is MMSI's EPS?

Diluted earnings per share over the last four quarters were $2.43; $0.65 in the latest quarter.

MMSI ownership and insider trades · All stocks